th ASX Announcement 28 October 2026 Atomo Q1 FY27 Quarterly Investor Webinar Presentation th SYDNEY Australia, 28 October 2026 – Atomo Diagnostics Limited (ASX: AT1) (Atomo or the Company) has updated the time of its Q1 FY27 Quarterly Investor webinar, hosted by CEO Cheri rd Walker & Financial...
Update - Investor Webinar Presentation
Filed with ASX · · 1 page · English
Summary by 6ix AI
The webinar will be hosted by CEO Cheri Walker and Financial Controller Suzy Elhlou. Atomo is a medical device company that specializes in rapid diagnostic test devices for various health applications.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
In the deck
Story so far
Earlier from Atomo Diagnostics
- Notification of cessation of securities - AT1
- Investor Webinar Presentation
- 2026 Notice of Annual General Meeting
- FY26 Results and Strategy Presentation
- 2026 Appendix 4E and Annual Report
Later from Atomo Diagnostics
- Atomo Signs Agreement with Innovation Scientific
- Quarterly Activities/Appendix 4C Cash Flow Report
- Q1 FY27 Results Presentation
- Change in substantial holding
Follow Atomo Diagnostics into a list and get an email when it puts out news.
Follow Atomo Diagnostics